Goldman Sachs’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58K | Buy |
+455
| New | +$5.58K | ﹤0.01% | 5080 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$98K | – | 5920 |
|
|
2021
Q4 | $98K | Buy |
+5
| New | +$98K | ﹤0.01% | 5230 |
|
|
2019
Q3 | – | Hold |
0
| – | -$9K | – | 4347 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4149 |
|
|
2016
Q3 | – | Hold |
0
| – | -$35K | – | 4658 |
|
|
2016
Q2 | – | Hold |
0
| – | -$22K | – | 4327 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4362 |
|